Carboxamide derivatives and pharmaceutical composition for use in preventing or treating mental illness containing the same as an active ingredient

• Main Authors: CHA EUNJU, BAE SERI, SONG MINSOO, PARK GA YOUNG, MABUNGA DARINE, SURESH PAUDEL, PARK DONGHYUN, SHIN CHAN YOUNG, PARK YOOJIN, CHO KYU SUK, KO EUN BI, KIM SOONG HYUN, KIM RYEONG EUN, JEON SE JIN, LEE EUNHYE, CHOI YUJEONG, KWON KYOUNG JA, IM CHUN YOUNG, SEO CHANG HOON, HWANG HEE JONG, KANG JIHEE
• Format: Patent
• Language: English; Korean
• Published: 07.12.2021
• Subjects: CHEMISTRY; FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HETEROCYCLIC COMPOUNDS; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; ORGANIC CHEMISTRY; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES

Disclosed are a carboxamide derivative and a pharmaceutical composition comprising the same as an active ingredient for preventing or treating mental illness. The derivative is excellent in a triple reuptake inhibitory effect of serotonin, norepinephrine, and dopamine, and thus can be usefully used in treating mental illness. 카복사미드 유도체 및 이를 유효성분으로 함유하는 정신질환의 예방 또는 치료용 약학적 조성물에 관한 것으로, 상기 유도체는 세로토닌, 노르에피네프린 및 도파민의 삼중 재흡수 억제 효과가 우수한 바, 정신질환의 치료에 유용하게 사용될 수 있다.